Study on correlation between the level of TSG-6 and the occurrence, development and prognosis of acute kidney injury(AKI)

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100051219

Enrollment

Unknown

Registered

2021-09-16

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury (AKI)

Interventions

AKI group:No

non AKI group:No

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 18-80 years; 2.Patients with clinical diagnosis of acute renal injury; 3.Patients were voluntarily included in the experiment, and all patients signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with previous chronic renal insufficiency; 2.Patients treated with glucocorticoid for more than 3 days; 3.Patients taking thyroxine tablets or antithyroid drugs for a long time; 4.Patients after organ transplantation or stem cell transplantation; 5.The etiology of AKI comes from pre-renal factors, post renal obstructive diseases, rapid progressive nephritis syndrome, acute interstitial nephritis and thrombotic microvascular disease; 6.Patients with malignant tumors and autoimmune diseases; 7.Other researchers considered it inappropriate to participate in the study.

Design outcomes

Primary

Measure	Time frame
tumor necrosis factor-inducible gene 6 protein;	—

Countries

China

Contacts

Public ContactChen Yue

Tongji Hospital

cy0818@126.com+86 13611924265

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026